Abstract |
|
Authors | Mee-Young Ahn, Tae-Hyung Kim, Seong-Min Kwon, Hyo-Eun Yoon, Hyung-Sik Kim, Jae-Il Kim, Yong-Chul Kim, Keon-Wook Kang, Sang-Gun Ahn, Jung-Hoon Yoon |
Journal | European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
(Eur J Pharm Sci)
Vol. 79
Pg. 122-31
(Nov 15 2015)
ISSN: 1879-0720 [Electronic] Netherlands |
PMID | 26342773
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2015 Elsevier B.V. All rights reserved. |
Chemical References |
- 5-nitro-5'-hydroxyindirubin-3'-oxime
- Antineoplastic Agents
- IGF1R protein, human
- Indoles
- Oximes
- Receptors, Somatomedin
- indirubin-3'-monoxime
- Receptor, IGF Type 1
- Oncogene Protein v-akt
|
Topics |
- Animals
- Antineoplastic Agents
(therapeutic use)
- Apoptosis
- Carcinoma, Non-Small-Cell Lung
(drug therapy)
- Cell Cycle
(drug effects)
- Cell Line, Tumor
- Humans
- Indoles
(pharmacology, therapeutic use)
- Lung Neoplasms
(drug therapy)
- MAP Kinase Signaling System
(drug effects)
- Male
- Mice
- Mice, Nude
- Neoplasm Transplantation
- Oncogene Protein v-akt
(antagonists & inhibitors)
- Oximes
(pharmacology, therapeutic use)
- Receptor, IGF Type 1
- Receptors, Somatomedin
(antagonists & inhibitors)
|